Margarida Tavares

Margarida Tavares

Auto-generated profile, based on publicly available information

Margarida Tavares

EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Portugal

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Obesity Research
Verified
Journal Article
Closed access
PDF file
PHPedro von Hafe
Pedro von Hafe
FPFrancisco Pina
Francisco Pina
APAna Pérez
Ana Pérez
MTMargarida Tavares
Margarida Tavares
HBHenrique Barros
Henrique Barros

29 March 2012 in Malaria Journal
Verified
Journal Article
Open access
PDF file
LSLurdes Santos
Lurdes Santos
CACandida Manuela Ferreira Abreu
Candida Manuela Ferreira Abreu
SXSandra M Xerinda
Sandra M Xerinda
MTMargarida Tavares
Margarida Tavares
RLRaquel Lucas
Raquel Lucas
ASAntónio C Sarmento
António C Sarmento
In view of the close relationship of Portugal with African countries, particularly former Portuguese colonies, the diagnosis of malaria is not a rare thing. When a traveller returns ill from endemic areas, malaria should be the number one suspect. World Health Organization treatment guidelines recommend that adults with severe malaria should be admitted to an intensive care unit (ICU).

1 September 1996 in Journal of Public Health
Verified
Journal Article
Open access
PDF file
HBHenrique Barros
Henrique Barros
MTMargarida Tavares
Margarida Tavares
TRTeresa Rodrigues
Teresa Rodrigues
It remains unclear if benefits of prenatal care can be attributed to the amount and content of care or to uncontrolled risk factors that might also affect its use. This study was designed to evaluate the independent association between prenatal care adequacy and adverse pregnancy outcomes, measured either as the occurrence of preterm birth or low birthweight. We studied 3734 single liveborn infants. Information on mothers' use of prenatal care, and demographic, anthropometric, behavioural, clinical and obstetric characteristics were obtained through questionnaire. Prenatal care was classified as inadequate, intermediate or adequate based on Kessner's Adequacy of Prenatal Care Index. To estimate the association of adequacy of prenatal care and the defined outcomes, both crude and adjusted odds ratios (OR) and 95 per cent confidence intervals (95 percent CI) were calculated by means of unconditional logistic regression. Adequate and intermediate (compared with inadequate) prenatal care was significantly associated with a lower risk of preterm (OR = 0⋅20, 95 per cent Cl 0⋅12–0⋅32, and OR = 0⋅35, 95 per cent Cl 0⋅23–0⋅54, respectively) or low birthweight (OR = 0⋅23, 95 per cent Cl 0⋅15–0⋅35, and OR = 0⋅31, 95 per cent Cl 0⋅20–0⋅46, respectively). After adjusting for maternal age, social class, marital status, complications of pregnancy and type of hospital, the risk of preterm delivery remained significantly lower for women receiving adequate (OR = 0⋅18, 95 per cent Cl 0⋅11–0⋅28) or intermediate care (OR = 0⋅35, 95 per cent Cl 0⋅23–0⋅54). Adjusted for maternal body mass index, marital status, cigarette smoking, pregnancy weight gain and complications, type of hospital, newborn sex and gestational age, a significant decreased risk of low birthweight remained for infants of women with adequate (OR = 0⋅39, 95 per cent Cl 0⋅23–0⋅65) or intermediate care (OR = 0⋅47, 95 per cent Cl 0⋅29–0⋅76). Our findings show that in a population with free access to prenatal care, the quantitative adequacy of prenatal care has an independent effect on pregnancy outcome, whether assessed through the occurrence of preterm births or low birthweight infants

2 February 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
NPNicole Pedro
Nicole Pedro
Claudio N. SilvaClaudio N. Silva
Claudio N. Silva
AMAna Cristina Magalhaes
Ana Cristina Magalhaes
BCBruno Cavadas
Bruno Cavadas
ARAna Mafalda Rocha
Ana Mafalda Rocha
MTMargarida Tavares
Margarida Tavares
A few molecularly proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases of symptomatic reinfection are currently known worldwide, with a resolved first infection followed by a second infection after a 48 to 142-day intervening period. We report a multiple-component study of a clinically severe and prolonged viral shedding coronavirus disease 2019 (COVID-19) case in a 17-year-old Portuguese female. She had two hospitalizations, a total of 19 RT-PCR tests, mostly positive, and criteria for releasing from home isolation at the end of 97 days. The viral genome was sequenced in seven serial samples and in the diagnostic sample from her infected mother. A human genome-wide array (>900 K) was screened on the seven samples, and in vitro culture was conducted on isolates from three late samples. The patient had co-infection by two SARS-CoV-2 lineages, which were affiliated in distinct clades and diverging by six variants. The 20A lineage was absolute at the diagnosis (shared with the patient’s mother), but nine days later, the 20B lineage had 3% frequency, and two months later, the 20B lineage had 100% frequency. The 900 K profiles confirmed the identity of the patient in the serial samples, and they allowed us to infer that she had polygenic risk scores for hospitalization and severe respiratory disease within the normal distributions for a Portuguese population cohort. The early-on dynamic co-infection may have contributed to the severity of COVID-19 in this otherwise healthy young patient, and to her prolonged SARS-CoV-2 shedding profile.

1 October 2013 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
BLBárbara Flor de Lima
Bárbara Flor de Lima
MTMargarida Tavares
Margarida Tavares

10 May 2022 in Breathe
Verified
Journal Article
Open access
PDF file
CNCláudio Nunes-Silva
Cláudio Nunes-Silva
AVAna Teresa Vilares
Ana Teresa Vilares
VSValentijn Schweitzer
Valentijn Schweitzer
SCSusana Castanhinha
Susana Castanhinha
AMAntónio Martins
António Martins
MTMargarida Tavares
Margarida Tavares
Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.Educational aims: To summarise the knowledge on the spectrum of disease that respiratory viral infections can cause and recognise how often they overlap. To learn the most common causes of respiratory viral infections and acknowledge other less frequent agents that may target certain key populations (e.g.immunocompromised patients). To improve awareness of the recent advances in diagnostic methods, including molecular assays and helpful features in imaging techniques. To identify supportive care strategies pivotal in the management of severe respiratory viral infections.